Carbon Monoxide Alarm & Carbon Monoxide Detector for RVs, Homes & Apartments, CO Alarms and CO Detectors

Today that its lead medication candidate announced.

Angiochem reports Phase 1/2 efficacy research results of ANG1005 for treating brain cancer Angiochem, Inc. A clinical-stage biotechnology firm developing medicines that are uniquely capable of crossing the blood-brain barrier to take care of brain diseases, today that its lead medication candidate announced, ANG1005, has demonstrated a good safety and efficacy account in a lot more than 100 patients with brain cancers from two separate Phase 1 /2 clinical studies in sufferers with progressive gliomas, including recurrent glioblastoma, and in patients with progressive human brain metastases herbal viagra .